
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Non small cell lung cancer physical examination
Introduction
Overview
Overview
Physical examination findings of non-small cell lung cancer will depend on the location of the tumor. Non-small cell lung cancer with central location may cause crackling sounds, focal wheezing, voice hoarseness, and tachypnea. Peripheral location can present with pleurisy findings. Common physical examination of patients with non-small cell lung cancer, include: crackling or bubbling noises, decreased/absent breath sounds, and whispered pectoriloquy.
Physical Examination
Physical Examination
The following physical examination findings may be present among patients with non-small cell lung cancer:[1][2]
- Physical examination findings of non small cell lung cancer can be completely normal during the early stage of malignancy.
- Patient may present with following findings in later stage of malignancy:
General appearance
- Well-appearing
- Older age in relation to chronological age
- Lethargic
- Confused
Vital Signs
- Low-grade fever
- Decreased oxygen saturation at room air
- Tachypnea
- Tachycardia
HEENT
Skin
CNS
Chest
Auscultation
- Present pleural friction rub
- Present egophony
- Crackling or bubbling noises
- Present whispered pectoriloquy
- Decreased/absent breath sounds
Percussion
- Hyporesonance
- Dull percussion
- Tactile fremitus
- Reduced chest expansion
Abdomen
Back
- Back examination of patients with non small cell lung cancer of the lung is usually normal.
Genitourinary
- Genitourinary examination of patients with non small cell lung cancer is usually normal.
Musculoskeletal
- Palpable soft-tissue mass
Extremities
References
References
- ↑ Hyde L, Hyde CI (1974). “Clinical manifestations of lung cancer”. Chest. 65 (3): 299–306. PMID 4813837.
- ↑ Ouziane I, Boutayeb S, Mrabti H, Lalya I, Rimani M, Errihani H (July 2014). “Sarcomatoid carcinoma of the lung: a model of resistance of chemotherapy”. N Am J Med Sci. 6 (7): 342–5. doi:10.4103/1947-2714.136920. PMC 4114013. PMID 25077084.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
